Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 351,322 shares at $62.70 ($22.1M) on 2025-10-16, disclosed to the SEC on 2025-10-20.
Scheduled sale ($22.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.65 | 2,792 | $175K | 0.8% |
| 2 | $62.65 | 2,792 | $175K | 0.8% |
| 3 | $62.69 | 17,001 | $1.1M | 4.8% |
| 4 | $62.69 | 17,001 | $1.1M | 4.8% |
| 5 | $62.70 | 39,111 | $2.5M | 11.1% |
| 6 | $62.70 | 16,667 |
| $1.0M |
| 4.7% |
| 7 | $62.70 | 16,667 | $1.0M | 4.7% |
| 8 | $62.70 | 39,332 | $2.5M | 11.2% |
| 9 | $62.70 | 39,332 | $2.5M | 11.2% |
| 10 | $62.70 | 39,111 | $2.5M | 11.1% |
| 11 | $62.71 | 39,531 | $2.5M | 11.2% |
| 12 | $62.71 | 39,531 | $2.5M | 11.2% |
| 13 | $63.39 | 2,335 | $148K | 0.7% |
| 14 | $63.39 | 2,335 | $148K | 0.7% |
| 15 | $63.46 | 8,423 | $535K | 2.4% |
| 16 | $63.46 | 8,423 | $535K | 2.4% |
| 17 | $63.49 | 10,469 | $665K | 3.0% |
| 18 | $63.49 | 10,469 | $665K | 3.0% |
| Total | $62.79 avg | 351,322 | $22.1M | 100% |
| Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |
| HIMS | SELL | 2025-07-23 | $9.9M | — | Filing → |